[Recommendations for follow-up of malignant diseases].
The follow up of patients after primary therapy of cancer is being made difficult by the large number of sometimes contradictory recommendations, but also by a lack of evidence in many diseases. A chance for cure or a longer life expectancy with earlier diagnosis of an asymptomatic recurrence exists in only a few diseases. For far more diseases, a symptom oriented follow-up with an emphasis on quality of life, treatment associated complications, evaluation of symptoms, and psychological support is recommended. In patients with a dislike of regular visits or in diseases without options for further treatment it will be sufficient if the patient returns in the case of complaints. Recommendations for follow-up in selected frequent cancers will be given, based mainly on the latest recommendations by the European Society for Medical Oncology (ESMO).
Eckert
R
R
Klinik für Onkologie, Gastroenterologie und allgemeine Innere Medizin, Städtische Kliniken Esslingen aN. r.eckert@kliniken-es.de
D001943:Breast Neoplasms / Q000628:therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000628:therapy; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D008207:Lymphatic Metastasis; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000628:therapy; D011788:Quality of Life; D012878:Skin Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy; D013997:Time Factors